Official Publications Gilead Sciences, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 08/12/2025 GMT			5-day change	1st Jan Change
121.19 ^USD	-0.02%		-2.53%	+31.20%

12-08	Assembly Biosciences Reports Positive Interim Results from Phase 1B Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates Abi-1179 and Abi-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirms Genital Herpes	CI
12-08	Gilead Sciences' Kite Says Yescarta Shows 'Consistent' Benefits in Large B-cell Lymphoma	MT

11-06	SEC Filing 10Q-3	CO
10-29	SEC Filing 8K	CO
10-29	Slide show Q3	CO
10-29	3rd quarter results	CO
08-06	SEC Filing 8K	CO
08-06	SEC Filing 10Q-2	CO
08-06	Slide show half-year results	CO
08-06	1st-half-year results	CO
05-06	Shareholders meeting voting results	CO
05-06	SEC Filing 10Q-1	CO
04-23	SEC Filing 8K	CO
04-23	Slide show Q1	CO
04-23	1st quarter results	CO
03-26	Proxy Statments	CO
02-27	SEC Filing 10K	CO
02-10	SEC Filing 8K	CO
02-10	Slide show results	CO
02-10	Annual results	CO
01-09	SEC Filing 13G	CO
12-18	SEC Filing 13G	CO
11-19	SEC Filing 8K	CO
11-11	SEC Filing 10Q-3	CO
11-06	SEC Filing 4K	CO
11-05	SEC Filing 4K	CO
11-05	Slide show Q3	CO

Time To Grow PFL Fanbase, Revenue: CEO John Martin

July 11, 2025 at 09:09 am